Cancer
Conditions
Keywords
care coordination, mobile health, chemotherapy, technology
Brief summary
The purpose of this study is to compare nurse-led care coordination for persons receiving cancer chemotherapy treatment incorporating mobile health technology to nurse-led care coordination without any mobile health enhancements.
Detailed description
This study will randomize sixty (60) participants receiving cancer chemotherapy treatment to receive nurse-led care coordination using a HIPAA-compliant mobile health platform compared to no technology-enhanced care coordination. All participants receive nurse-led care coordination throughout chemotherapy treatment. RESEARCH AIMS: * Demonstration of a HIPAA-compliant social networking platform; * Facilitate communication and collaboration among patients with cancer and their care team; * Assess patient health outcomes (chemotherapy-related physical and psychological side effects; pain, quality of life and patient satisfaction) * Assessment of healthcare utilization including emergency department visits, unplanned clinic visits and hospitalization; * For patients assigned to the mobile health care coordination, understanding their experience of use of the technology
Interventions
Participants receive care coordination throughout their chemotherapy treatment using mHealth technology
OTHERNo mHealth
Participants receive the same evidence-based care coordination without mHealth technology
Sponsors
McKesson Foundation
Boston University
University of California, Davis
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years or older * Newly diagnosed cancer - any site or stage * Initiating chemotherapy * Ability to read and write English * Manual dexterity sufficient to use a tablet technology * Cognitive capacity to participate * Preferential recruitment of publicly insured and/or living in rural communities
Exclusion criteria
* Oral chemotherapy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Patient Health Outcome | Baseline, 3 months, 6 months | Pain |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Demonstration of a HIPAA-compliant platform to coordinate care overtime | Baseline, 6 months | * Technology Usability and Acceptance * Patient engagement with technology * Use of electronic medical record features to communicate with providers |
Other
| Measure | Time frame | Description |
|---|---|---|
| Change in Patient Health Outcomes | Baseline, 3 months, 6 months | * Treatment related symptoms * Psychological Distress * Quality of Life |
| Change in Healthcare Outcomes | Baseline, 6 months | * Processes of care coordination * Patient engagement * Patient satisfaction |
| Change in Healthcare Utilization | Baseline, 3 months, 6 months | * Emergency department visits * Unplanned hospitalizations * Unplanned clinic visits |
| Mobile health usability overtime | 2 weeks, 8 weeks | Guided interviews with technology group to assess understanding and usability of the mobile technology platform to communicate and coordinate care |
Countries
United States
Outcome results
None listed